Claire Ponsart

Dr. Claire Ponsart

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Animal Reproduction Science
Verified
Journal Article
Closed access
BGB. Grimard
B. Grimard
SFS. Freret
S. Freret
ACA. Chevallier
A. Chevallier
APA. Pinto
A. Pinto
CPClaire Ponsart
Claire Ponsart
PHP. Humblot
P. Humblot

20 March 2012 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
CRCharlène Rico
Charlène Rico
LDLaurence Drouilhet
Laurence Drouilhet
PSPascal Salvetti
Pascal Salvetti
RDRozenn Dalbiès-Tran
Rozenn Dalbiès-Tran
PJPeggy Jarrier
Peggy Jarrier
DMDanielle Monniaux
Danielle Monniaux
High between-animal variability in the number of embryos produced by multiple ovulation and embryo transfer (MOET) and ovum pick-up and in vitro production (OPU–IVP) methods remains a major limit to the development of embryo biotechnologies in cattle. The measurement of anti-Müllerian hormone (AMH) endocrine concentrations in cows can help to predict their follicular and ovulatory responses to gonadotrophin treatment. The present study aimed to provide practical information for a simple prognostic method based on AMH measurement in Holstein cows. Accurate AMH concentrations could be measured with ELISA in blood or plasma. In cows undergoing repeated OPU protocols over 1 year, the AMH concentrations measured in plasma samples collected before each gonadotrophin treatment were found to be highly repeatable and were tightly correlated with follicular responses. From data obtained at both an experimental station and farm settings, it was possible to propose AMH cut-off values to identify low-responding cows. Gonadotrophin-stimulated cows producing fewer than 15 large follicles at oestrus and fewer than 10 embryos in MOET protocols could be discarded efficiently with plasma AMH concentrations below 87 and 74 pg mL–1, respectively. In conclusion, we propose a prognostic method based on a single AMH measurement to improve the results of embryo biotechnologies.

22 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAurélie Allais-Bonnet
Aurélie Allais-Bonnet
CGCécile Grohs
Cécile Grohs
IMIvica Medugorac
Ivica Medugorac
SKStefan Krebs
Stefan Krebs
ADAnis Djari
Anis Djari
ACAurélien Capitan
Aurélien Capitan
Despite massive research efforts, the molecular etiology of bovine polledness and the developmental pathways involved in horn ontogenesis are still poorly understood. In a recent article, we provided evidence for the existence of at least two different alleles at the Polled locus and identified candidate mutations for each of them. None of these mutations was located in known coding or regulatory regions, thus adding to the complexity of understanding the molecular basis of polledness. We confirm previous results here and exhaustively identify the causative mutation for the Celtic allele (PC) and four candidate mutations for the Friesian allele (PF). We describe a previously unreported eyelash-and-eyelid phenotype associated with regular polledness, and present unique histological and gene expression data on bovine horn bud differentiation in fetuses affected by three different horn defect syndromes, as well as in wild-type controls. We propose the ectopic expression of a lincRNA in PC/p horn buds as a probable cause of horn bud agenesis. In addition, we provide evidence for an involvement of OLIG2, FOXL2 and RXFP2 in horn bud differentiation, and draw a first link between bovine, ovine and caprine Polled loci. Our results represent a first and important step in understanding the genetic pathways and key process involved in horn bud differentiation in Bovidae.

25 October 2013 in Veterinary Microbiology
Verified
Journal Article
Closed access
KWKerstin Wernike
Kerstin Wernike
BHBernd Hoffmann
Bernd Hoffmann
EBEmmanuel Bréard
Emmanuel Bréard
ABAnette Bøtner
Anette Bøtner
CPClaire Ponsart
Claire Ponsart
MBMartin Beer
Martin Beer


31 August 2023 in Emerging Microbes & Infections
Verified
Journal Article
Open access
VDVitomir Djokic
Vitomir Djokic
LFLuca Freddi
Luca Freddi
FMFabrizio de Massis
Fabrizio de Massis
ELElina Lahti
Elina Lahti
MEMarielle H. van Den Esker
Marielle H. van Den Esker
CPClaire Ponsart
Claire Ponsart
The zoonotic bacteria, Brucella canis, is becoming the leading cause of canine brucellosis in Europe. In dogs, it causes reproductive problems as well as non-specific lameness or discospondilitis. In humans, B. canis can be origin of chronic debilitating conditions characteristic to its genus such as undulant fever, splenomegaly, and lymphadenopathy. Although B. canis shows some pathogenic characteristics similar to B. abortus and B. melitensis, it lacks surface O-polysaccharide, like nonzoonotic B. ovis. This review shows that host-B. canis interactions are still poorly understood, with many knowledge and capability gaps, causing relatively poor sensitivity and specificity of existing diagnostic tools. Currently, there is no vaccine for this rough Brucella species. Besides, antimicrobial therapy does not guarantee bacterial elimination, and infection relapses are frequently reported, increasing the risks of antibiotic resistance development. B. canis has been detected in dogs in almost all European countries which increased human exposure, but currently there is no systematic surveillance. Moreover, B. canis caused brucellosis is not included in Animal Health Law, and therefore there is no legal framework to tackle this emerging infectious disease. To map out the diagnostic strategies, identify risks for human infections and propose management scheme for infected pet and kennel dogs, we present current understanding of canine B. canis caused brucellosis, outline major knowledge gaps and propose future steps. To address and highlight challenges veterinary and public health services encounter in Europe, we developed two B. canis infection scenarios: of a single household pet and of a kennel dog in larger group.